SmartPill Testing to Begin at Wake Forest University

Wake Forest Baptist Medical Center became the third 510(k) clinical trial site for the SmartPill Capsule -- a noninvasive, ingestible medical device that captures biomedical data from within a patient's GI tract. The SmartPill Corporation announced the trials will begin next week with a total of 25 subjects -- 15 who are healthy and 10 who have been documented with gastroparesis, the inability of the stomach to empty, are expected to participate in the study.

LocalTechWire.com

(http://www.localtechwire.com/article.cfm?u=11082)